Quick Summary
Covering the latest research from top Wall Street investment banks

Maintain Buy on Robotis: Capacity expansion and humanoid robot progress support high growth

Institution
Goldman Sachs
Date
2026-08-16
Authors
Do Hyoung Kim, Joshua Kim
Company
Robotis
Ticker
108490.KQ
Industry
Robotics
Rating
Buy
BullishHigh confidenceGoldman Sachs believes Robotis's growth thesis remains intact: 2Q26 revenue and operating profit rose significantly, while Uzbekistan capacity ramp-up, humanoid robot product progress, and Korean humanoid robot demand will provide subsequent catalysts.
AuthorsDo Hyoung Kim, Joshua Kim
Target priceW630,000
SubsidiariesRobotis AI
Business segmentsActuators、Humanoid robots、Autonomous mobile robots (AMRs)
Research firm divisions/subsidiariesGoldman Sachs(Other)

AI summary card

Maintain Buy on Robotis: Capacity expansion and humanoid robot progress support high growth

Robotis's 2Q26 revenue rose 95% YoY and operating profit increased 723% YoY; Goldman Sachs expects Uzbekistan capacity to ramp up in 2H26 and maintains its W630,000 target price.

Buy; 12-month target price of W630,000, versus the report's listed share price of W280,000, implying 125.0% upside.
RobotisRoboticsHumanoid robotsActuatorsCapacity expansionKorea
  • Goldman Sachs expects 2026 revenue to increase 153% YoY, with full-year operating profit of approximately W3bn.
  • The company was unable to fully meet core customer actuator demand in the first half, with an order fulfillment rate of approximately 66%; the capacity bottleneck is the key near-term constraint.
  • AI Sapiens achieves software-only iteration for humanoid robots through NVIDIA Isaac Sim and reinforcement learning, with simulation-trained strategies deployable to physical robots in about 3 hours.
  • Goldman Sachs expects Robotis to sell 800 humanoid robots externally next year and believes Korea's robotics sector could be catalyzed by events such as Unitree's listing.

Report interpretation

Overview

This report reiterates a positive view following Robotis's 2Q26 results. Goldman Sachs places greater emphasis on annual growth trends in the early-stage robotics industry than on quarterly volatility, believing that actuator demand, overseas capacity expansion, and humanoid robot commercialization progress will accelerate revenue and profit.

Core views

Robotis's core growth thesis remains intact. 2Q26 results demonstrate a strong growth trajectory, but current capacity constrained actuator deliveries; as Uzbekistan capacity ramps up in 2H26 and Korea further expands capacity, revenue and profit are expected to improve materially. AI Sapiens's enhanced software capabilities, open-source strategy, and potential government demand reinforce the humanoid robot opportunity.

Analysis framework

Uses a top-down analysis of industry catalysts and a bottom-up analysis of company operations, focusing on annual revenue/profit trends, actuator supply constraints, capacity expansion, humanoid robot product maturity, and valuation opportunities across Korea's robotics supply chain.

Methodology notes

  • Factor analysisGS Factor Profile

    Comparison of growth, financial returns, valuation, and composite factors

    Goldman Sachs uses standardized rankings and percentiles to compare stocks with their covered market and industry peers; growth references forward sales, EBITDA, and EPS growth, financial returns reference forward ROE, ROCE, and CROCI, and valuation references forward P/E, P/B, EV/EBITDA, and other metrics.

  • M&A frameworkM&A Rank

    Classification of potential acquisition probability

    Goldman Sachs categorizes covered companies into ranks 1 to 3 based on qualitative and quantitative factors; Rank 1 represents a higher potential probability of acquisition, while Rank 3 represents a lower probability. The report's table shows Robotis has an M&A Rank of 3.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Robotis (108490.KQ)
    Core covered stock
    Strengths
    Strong demand for the actuator business; Uzbekistan capacity expansion provides supply flexibility; AI Sapiens has made notable progress in humanoid robot movement and dexterity; it offers relatively scarce pure-play robotics exposure.
    Weaknesses
    Current insufficient capacity constrains deliveries; Robotis AI's AMR business remains in a slow ramp-up and loss-making stage.
    Comparison
    Compared with auto parts companies that also have traditional businesses, Robotis offers purer exposure to humanoid robots and actuators.
    Risks
    Delayed capacity ramp-up, demand conversion below expectations, slower humanoid robot commercialization, widening AMR losses, and high-valuation volatility.
  • HLMando
    Korea robotics/actuator supply-chain related stock
    Strengths
    Goldman Sachs maintains Buy; current valuation can largely be explained by the traditional core business, while investors gain additional robotics actuator exposure.
    Weaknesses
    The robotics business is not the sole valuation driver.
    Comparison
    Compared with Robotis, it has lower robotics business purity, but its traditional business provides valuation support.
    Risks
    Robotics business contribution falls short of expectations and volatility in the core auto parts business.
  • Hyundai Mobis
    Korea robotics supply-chain related stock
    Strengths
    Goldman Sachs maintains Buy (on CL); the valuation foundation of its traditional business makes the robotics-related optionality attractive.
    Weaknesses
    Robotics exposure is more indirect than Robotis's.
    Comparison
    Compared with Robotis, it has lower sensitivity to the robotics theme but a more mature business foundation.
    Risks
    Cyclicality in the traditional automotive business and robotics-related investment returns falling short of expectations.

Key data

  • 2Q26 revenue YoY growth95%The report states that 2Q26 revenue grew 95%.
  • 2Q26 operating profit YoY growth723%The report states that 2Q26 operating profit grew 723%.
  • 2026 revenue forecastW98.3bnShown in the report table; Goldman Sachs expects 153% YoY growth in the text.
  • 2027 revenue forecastW200.5bnShown in the report table.
  • 2026 operating profit forecastW3bnForecast in the text; 1Q26 recorded a -W12bn loss due to stock-compensation-related expenses.
  • Core customer actuator demand fulfillment rateApproximately 66%The company stated that it could not meet all demand in the first half of 2026.
  • Forecast external humanoid robot shipments next year800 unitsGoldman Sachs model forecast.
  • Target price and upsideW630,000; 125.0%Calculated based on the report's listed share price of W280,000.

Impact & implications

If capacity bottlenecks are resolved as planned, backlog and unmet actuator demand could translate into faster revenue recognition; improvements in humanoid robot hardware and software capabilities, together with an open-source ecosystem strategy, are expected to expand Robotis's standardization opportunity in Korea's humanoid robot supply chain. Maintaining the Buy rating without changes to EPS or the target price indicates that the investment thesis is primarily driven by execution and capacity delivery.

Risks

  • New capacity ramp-up in Uzbekistan and Korea is slower than expected.
  • Actuator orders, backlog, or customer demand cannot be converted into revenue as expected.
  • Robotis AI's AMR business continues to incur losses or commercializes more slowly than expected.
  • Humanoid robot procurement demand, policy support, or industry capital enthusiasm weakens.
  • The robotics industry remains at an early stage, quarterly data bases are small, and earnings and valuations may be highly volatile.

What to watch

  • Commissioning of Uzbekistan capacity and delivery improvements in 2H26.
  • Actuator demand fulfillment rates, backlog digestion, and the pace of revenue recognition.
  • AI Sapiens product demonstrations at the World Robot Conference and subsequent customer applications, open-source ecosystem developments, and order progress.
  • Korean government humanoid robot procurement plans and potential investment trends from the Korea Growth Fund.
  • Robotis AI loss narrowing and AMR business ramp-up.
  • The impact of industry events, such as Unitree's listing, on attention and valuations in Korea's robotics sector.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins